Lumexa Imaging (NASDAQ:LMRI) Trading 10.5% Higher – Still a Buy?

Shares of Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI) traded up 10.5% on Wednesday . The company traded as high as $9.25 and last traded at $9.50. 80,066 shares were traded during trading, a decline of 90% from the average session volume of 821,397 shares. The stock had previously closed at $8.60.

Analysts Set New Price Targets

Separately, Raymond James Financial upgraded Lumexa Imaging from an “outperform” rating to a “strong-buy” rating and set a $23.00 price target for the company in a report on Monday, February 9th. One analyst has rated the stock with a Strong Buy rating, Based on data from MarketBeat, the stock presently has a consensus rating of “Strong Buy” and a consensus price target of $23.00.

Lumexa Imaging Trading Down 0.5%

The company has a 50 day simple moving average of $12.88.

Lumexa Imaging (NASDAQ:LMRI) last issued its quarterly earnings results on Thursday, March 26th. The company reported ($0.66) EPS for the quarter, missing the consensus estimate of $0.05 by ($0.71). The firm had revenue of $1.02 billion for the quarter, compared to analyst estimates of $262.72 million.

Institutional Trading of Lumexa Imaging

Institutional investors and hedge funds have recently modified their holdings of the business. Assetmark Inc. acquired a new stake in shares of Lumexa Imaging during the 4th quarter worth approximately $36,000. Barclays PLC acquired a new position in Lumexa Imaging during the 4th quarter worth $133,000. Sandia Investment Management LP bought a new position in shares of Lumexa Imaging in the fourth quarter worth $185,000. Hudson Bay Capital Management LP bought a new position in shares of Lumexa Imaging in the fourth quarter worth $237,000. Finally, Oxford Asset Management LLP acquired a new position in shares of Lumexa Imaging during the fourth quarter valued at $670,000.

Lumexa Imaging Company Profile

We are one of the largest national providers of diagnostic imaging services(1). Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of September 30, 2025, we and our affiliates operated the second largest(1) outpatient imaging center footprint in the United States. It spans 184 centers(2)across 13 states and includes eight joint venture partnerships with health systems. Our centers are in attractive metropolitan statistical areas (“MSAs”).